FIRST EXTENSION - GRANTED
granted
on 24 Jun 2024
Last Applicant/ Owned by
635 Davis Drive, Suite 400
Morrisville
NC
27560
Serial Number
97424017 filed on 23rd May 2022
Registration Number
N/A
Correspondent Address
Keith Toms, Esq.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
IMMORNA
Research and development of messenger RNA (mRNA) biotechnologies; Research and development services in the field of biologics, including but not limited to mRNA, RNA, DNA, antibodies, vaccines, and peptides; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consulting s Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development of messenger RNA (mRNA) biotechnologies; Research and development services in the field of biologics, including but not limited to mRNA, RNA, DNA, antibodies, vaccines, and peptides; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostic services for scientific research purposes, and pharmacogenetics; conducting research and clinical trials for others in the field of biotechnology, pharmaceutical research and development, laboratory testing, diagnostic services for scientific research purposes, and pharmacogenetics; Scientific research, namely, mRNA synthesis, purification and testing
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Messenger RNA (mRNA) pharmaceutical and biopharmaceutical preparations for use in the treatment of oncological diseases and disorders, infectious diseases, autoimmune and genetic diseases and disorders, and for use in medical cosmetology; messenger RNA (mRNA) pharmaceutical and biopharmaceutical preparations for vaccines; Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; Pharmaceutical preparations and substances for the treatment of infectious diseases; vaccines; pharmaceutical preparations and substances for the treatment of autoimmune diseases and disorders, autoimmune deficiency; pharmaceutical preparation and substances for the treatment of genetic disorders; pharmaceutical preparations and substances for use in medical cosmetology; diagnostic biomarker reagents for medical purposes; protein arrays for medical diagnosis purposes; diagnostic preparations for medical purposes for detecting the presence of tumors, infectious diseases, genetic disorders and autoimmune disorders and conditions; drug delivery agents in the form of polymer and lipid nanoparticles for delivery of mRNA being a pharmaceutical preparation; drug delivery agents in the form of nanoparticles and capsids for delivery for a wide variety of therapeutic agents
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Reagents for scientific, research, and medical research use; chemical reagents other than for medical purposes; diagnostic reagents for clinical or medical laboratory use; mRNA reagents for scientific, research, and medical research use; reagents comprised of nanoparticles for scientific, research, and medical research use; reagents, comprised of capsids for scientific, research, and medical research use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Manufacture of nanoparticles and capsids for use in connection with mRNA-based therapeutics for others
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97424017
Mark Type
No Service Mark
Attorney Docket Number
No 137409-00101
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Dec 2024 | SOU TEAS EXTENSION RECEIVED |
| 25th Jun 2024 | SOU EXTENSION 1 GRANTED |
| 25th Jun 2024 | SOU EXTENSION 1 FILED |
| 25th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 24th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
| 26th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 31st Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 31st Oct 2023 | PUBLISHED FOR OPPOSITION |
| 11th Oct 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 21st Sep 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |